Bipartisan Legislation Introduced to Increase Access to Biosimilars in Medicare Plans

Publication Date13 May 2021
SubjectMedicare,Life Sciences,Health Insurance,Prescription Drugs,Biosimilars,Legislative Agendas,Biologics,Healthcare Reform,Pharmaceutical Industry
AuthorBrian Drummond
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT